Alpha DaRT, a unique localized alpha radiation therapy, has shown potential best-in-class efficacy and safety across multiple solid tumors. Currently enrolling patients in cSCC, HNSCC, pancreatic, and ...
For permission requests, please contact NEJM Reprints at [email protected] In spite of great progress in the knowledge of the chemistry and physiologic function of the pituitary hormones no truly ...
LONDON, UK, 4 March 2025 - In a comprehensive Genomic Press Viewpoint (review) article, researchers are shining a spotlight on a revolutionary approach to tackling neuroendocrine tumours (NETs), a ...
Patients are often stabilised for years on somatostatin analogues; however, progression eventually necessitates disease‑controlling therapy. Clinically, the somatostatin receptor subtype 2 (SSTR2) ...
Alpha Tau Medical’s proprietary Alpha DaRT device safely delivers alpha radiation with localized precision to treat cancers. Alpha Tau is waiting for FDA feedback to initiate a US pivotal trial in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback